EX-99 2 e613917_ex99.htm Unassociated Document
 
Joint Filer Information

Names:
Deerfield Mgmt, L.P.,  Deerfield Management Company, L.P.,
Deerfield Partners, L.P., Deerfield International Master Fund, L.P.
   
Address:
780 Third Avenue, 37th Floor
New York, NY  10017
   
Designated Filer:
James E. Flynn
   
Issuer and Ticker Symbol:
Antares Pharma, Inc. [ATRS]
   
Date of Earliest Transaction
Required To be Reported:
July 6, 2015
 
The undersigned, Deerfield Mgmt, L.P.,  Deerfield Management Company, L.P., Deerfield Partners, L.P. and Deerfield International Master Fund, L.P. are jointly filing the attached amendment to Statement of Changes in Beneficial Ownership on Form 4 with James E. Flynn with respect to the beneficial ownership of securities of Antares Pharma, Inc.
 
Signatures:
 
DEERFIELD MGMT, L.P.
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
DEERFIELD PARTNERS, L.P.
By:  Deerfield Mgmt, L.P., General Partner
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
DEERFIELD MANAGEMENT COMPANY, L.P.
By:  Flynn Management LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
DEERFIELD INTERNATIONAL MASTER FUND, L.P.
By:  Deerfield Mgmt, L.P., General Partner
By:  J.E. Flynn Capital, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact